Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 34Esophageal Neoplasms 19Pancreatic Neoplasms 9Esophageal Squamous Cell Carcinoma 6Stomach Neoplasms 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 3Resectable Esophageal Cancer 2Pathologic Complete Response 2Neoplasms by Site 2Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Thrombocytopenia 1Rectal Malignant Neoplasms 1Rectal Diseases 1Radiation Injuries 1Postoperative Complications 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pancreatic Cancer Non-resectable 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Histologic Type 1Margins of Excision 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Locally Advanced Rectal Cancer 1

Interventions

irinotecan sucrosofate 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1DNA Fingerprinting 1Chemoradiotherapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × Chemoradiotherapy × Gastrointestinal × Clear all
NCT01037049 2018-09-17

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Royal Marsden NHS Foundation Trust

Phase 2 Unknown
237 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡